Tumor pseudoprogression following radiosurgery for vestibular schwannoma

Abstract

We sought to characterize vestibular schwannoma (VS) pseudoprogression after radiosurgery to assess its incidence, causative factors, and association with radiation-induced adverse effects. We performed a retrospective study of VS treated with Gamma Knife radiosurgery during 2005-2009. Seventy-five patients had at least 24 months of clinical and radiographic follow-up (median, 29 months) and were included. Tumor response was calculated volumetrically using Gamma plan software on consecutive MRIs. All treatment plans were reviewed for dosimetry characteristics. Forty-nine VS (65%) were stable or regressed after treatment. Seventeen (23%) underwent pseudoprogression, with onset of enlargement at 6 months. Seven (9%) remained larger than initial treatment volume at last follow-up. Nine (12%) had persistent growth. Three patients underwent subsequent microsurgery. One patient required intervention at 3 months for cystic enlargement; otherwise, all patients with progressive enlargement had stable VS until at least 24 months. Twenty-six patients (34.7%) developed nonauditory adverse radiation effects after treatment, including cranial neuropathy, ataxia, and hydrocephalus. There was no statistical association between onset of clinical deterioration and tumor response. Volume changes in the first 24 months after radiosurgery rarely herald treatment failure. Any volume change after 24 months is indicative of treatment failure. Pseudoprogression does not appear to be independently linked to radiation-induced morbidity, and there are no patient-related or radiosurgical parameters that predict tumor response.